Average Co-Inventor Count = 9.88
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (22 from 2,405 patents)
2. Schering Corporation (14 from 1,829 patents)
3. Pharmacopeia Drug Discovery, Inc. (6 from 52 patents)
4. Pharmacopeia Inc. (2 from 101 patents)
5. Merck Sharp + Dohme B.v. (1 from 55 patents)
6. Scheeing Corporation (1 from 1 patent)
37 patents:
1. 12281109 - Inhibitors of histone deacetylase-3 useful for the treatment of cancer, inflammation, neurodegeneration diseases and diabetes
2. 12246008 - 4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channels
3. 10822338 - Substituted aminoquinazoline compounds as Aantagonist
4. 10472347 - Aminopyrazine compounds with A2A antagonist properties
5. 10392353 - Processes for making substituted quinazoline compounds using hydrogen bonding catalysts
6. 10246457 - Indazole and azaindazole Btk inhibitors
7. 10130630 - BTK inhibitors
8. 10093683 - Factor XIa inhibitors
9. 10011615 - Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
10. 9834554 - BTK inhibitors
11. 9718828 - BTK Inhibitors
12. 9676780 - [object Object]
13. 9499502 - 5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use
14. 9481682 - Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
15. 9469615 - [object Object]